Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Multiple Sclerosis Center of Atlanta (MSCA) is a premier non-profit healthcare organization dedicated to providing comprehensive care and support for individuals living with multiple sclerosis and related neurological disorders. Founded in 2001, the center integrates advanced clinical treatment, diagnostic services, and cutting-edge clinical research to improve patient outcomes. MSCA serves as a major hub for clinical trials in the Southeastern United States, partnering with global pharmaceutical companies to evaluate new therapeutic candidates. Their multidisciplinary approach includes specialized neurology, infusion services, rehabilitation, and social support. As a designated Center for Comprehensive MS Care, MSCA is committed to advancing the standard of care through both direct patient services and significant contributions to clinical science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Multiple Sclerosis Center of Atlanta.